| regulation of transforming growth factor beta secretion | GO:2001201 | 1 | 0.991 | |
| transforming growth factor beta secretion | GO:0038044 | 1 | 0.970 | |
| positive regulation of transforming growth factor beta secretion | GO:2001203 | 1 | 0.966 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.430 | Mouse |
| regulation of microvillus assembly | GO:0032534 | 3 | 0.375 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.318 | Mouse |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.295 | |
| regulation of microvillus organization | GO:0032530 | 3 | 0.270 | |
| regulation of interleukin 10 secretion | GO:2001179 | 4 | 0.256 | |
| chemotaxis | GO:0006935 | 247 | 0.247 | |
| erythrocyte maturation | GO:0043249 | 6 | 0.231 | |
| mitral valve morphogenesis | GO:0003183 | 4 | 0.220 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.202 | |
| regulation of cell motility | GO:2000145 | 236 | 0.199 | |
| hemangioblast cell differentiation | GO:0060217 | 1 | 0.194 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.194 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.175 | |
| positive regulation of auditory receptor cell differentiation | GO:0045609 | 1 | 0.170 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.168 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.161 | |
| endocardial cushion to mesenchymal transition involved in heart valve formation | GO:0003199 | 4 | 0.160 | |
| regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000800 | 1 | 0.160 | |
| blood coagulation | GO:0007596 | 76 | 0.154 | |
| cytokine production | GO:0001816 | 319 | 0.147 | |
| negative regulation of endothelial cell migration | GO:0010596 | 4 | 0.145 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.145 | Mouse |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.142 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.131 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.131 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.128 | |
| mitral valve development | GO:0003174 | 4 | 0.126 | |
| positive regulation of synaptic plasticity | GO:0031915 | 4 | 0.125 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.122 | |
| aortic valve morphogenesis | GO:0003180 | 4 | 0.119 | |
| positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process | GO:2000763 | 1 | 0.115 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.115 | |
| negative regulation of oxidative phosphorylation uncoupler activity | GO:2000276 | 2 | 0.114 | |
| interleukin 10 secretion | GO:0072608 | 4 | 0.113 | |
| semaphorin plexin signaling pathway involved in outflow tract morphogenesis | GO:0071527 | 1 | 0.112 | |
| negative regulation of blood vessel endothelial cell migration | GO:0043537 | 3 | 0.109 | |
| positive regulation of inner ear receptor cell differentiation | GO:2000982 | 1 | 0.108 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.107 | |
| activation of immune response | GO:0002253 | 138 | 0.099 | |
| cellular homeostasis | GO:0019725 | 240 | 0.094 | |
| regulation of exit from mitosis | GO:0007096 | 1 | 0.094 | |
| circadian rhythm | GO:0007623 | 114 | 0.093 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.091 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.090 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.090 | |
| intracellular distribution of mitochondria | GO:0048312 | 1 | 0.090 | |
| embryonic heart tube formation | GO:0003144 | 1 | 0.090 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.087 | |
| positive regulation of keratinocyte proliferation | GO:0010838 | 4 | 0.085 | |
| neuron migration | GO:0001764 | 122 | 0.082 | |
| cell proliferation involved in outflow tract morphogenesis | GO:0061325 | 4 | 0.081 | |
| cardiac neural crest cell migration involved in outflow tract morphogenesis | GO:0003253 | 3 | 0.079 | |
| regulation of intestinal epithelial structure maintenance | GO:0060730 | 1 | 0.079 | |
| regulation of protein localization | GO:0032880 | 231 | 0.079 | |
| regulation of oxidative phosphorylation uncoupler activity | GO:2000275 | 3 | 0.076 | |
| cell adhesion | GO:0007155 | 329 | 0.074 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.073 | Mouse |
| cellular response to external stimulus | GO:0071496 | 88 | 0.070 | |
| protein secretion | GO:0009306 | 111 | 0.070 | |
| regulation of cell migration | GO:0030334 | 219 | 0.068 | |
| regulation of hemostasis | GO:1900046 | 28 | 0.067 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.067 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.066 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.066 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.066 | |
| transdifferentiation | GO:0060290 | 1 | 0.065 | |
| innate immune response | GO:0045087 | 157 | 0.064 | |
| digestion | GO:0007586 | 40 | 0.064 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.062 | |
| cell differentiation involved in embryonic placenta development | GO:0060706 | 26 | 0.059 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.059 | |
| cardiac right ventricle formation | GO:0003219 | 3 | 0.058 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.057 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.056 | |
| negative regulation of synapse maturation | GO:2000297 | 2 | 0.056 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.055 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.055 | |
| intestinal epithelial structure maintenance | GO:0060729 | 4 | 0.054 | |
| respiratory gaseous exchange | GO:0007585 | 43 | 0.053 | |
| regulation of monocyte chemotaxis | GO:0090025 | 3 | 0.052 | |
| hemostasis | GO:0007599 | 78 | 0.052 | |
| cation homeostasis | GO:0055080 | 212 | 0.051 | |
| positive regulation of angiogenesis | GO:0045766 | 46 | 0.051 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.050 | |
| auditory receptor cell fate specification | GO:0042667 | 1 | 0.049 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.049 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.049 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.049 | |
| regulation of mast cell differentiation | GO:0060375 | 3 | 0.048 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.048 | |
| epithelial cell morphogenesis | GO:0003382 | 41 | 0.048 | |
| positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000802 | 1 | 0.048 | |
| regulation of auditory receptor cell differentiation | GO:0045607 | 4 | 0.047 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.047 | |
| t helper 17 cell chemotaxis | GO:0035705 | 1 | 0.047 | |
| platelet morphogenesis | GO:0036344 | 13 | 0.045 | |
| coagulation | GO:0050817 | 78 | 0.044 | |
| regulation of neural retina development | GO:0061074 | 3 | 0.044 | |
| pancreatic a cell fate commitment | GO:0003326 | 2 | 0.044 | |
| immune effector process | GO:0002252 | 321 | 0.044 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.044 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.044 | |
| pancreatic pp cell differentiation | GO:0003312 | 2 | 0.043 | |
| carbohydrate transport | GO:0008643 | 62 | 0.043 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.043 | |
| regulation of erythrocyte differentiation | GO:0045646 | 23 | 0.043 | |
| negative regulation of myeloid cell differentiation | GO:0045638 | 38 | 0.042 | |
| regulation of system process | GO:0044057 | 200 | 0.042 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.042 | |
| regulation of retina development in camera type eye | GO:1902866 | 3 | 0.042 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.042 | |
| protein ubiquitination | GO:0016567 | 171 | 0.042 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.041 | |
| amide transport | GO:0042886 | 138 | 0.041 | |
| catecholamine metabolic process | GO:0006584 | 30 | 0.041 | |
| immune response regulating cell surface receptor signaling pathway | GO:0002768 | 80 | 0.040 | |
| embryonic placenta development | GO:0001892 | 98 | 0.040 | |
| norepinephrine transport | GO:0015874 | 2 | 0.040 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.040 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.039 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.039 | |
| positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis | GO:2000764 | 1 | 0.039 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.038 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.038 | |
| mitochondrion distribution | GO:0048311 | 4 | 0.038 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.038 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.038 | |
| t cell differentiation | GO:0030217 | 174 | 0.038 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.037 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.037 | |
| histone acetylation | GO:0016573 | 41 | 0.037 | |
| transmembrane transport | GO:0055085 | 412 | 0.037 | |
| negative regulation of peroxisome proliferator activated receptor signaling pathway | GO:0035359 | 3 | 0.036 | |
| amine metabolic process | GO:0009308 | 45 | 0.036 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.035 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.035 | |
| immune response activating cell surface receptor signaling pathway | GO:0002429 | 72 | 0.035 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.035 | |
| pancreatic pp cell fate commitment | GO:0003329 | 2 | 0.035 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.035 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.035 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.035 | |
| glucose homeostasis | GO:0042593 | 128 | 0.034 | |
| cytokine secretion | GO:0050663 | 72 | 0.034 | |
| mature dendritic cell differentiation | GO:0097029 | 3 | 0.034 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.034 | |
| neuron projection guidance | GO:0097485 | 141 | 0.033 | |
| cell proliferation involved in heart valve development | GO:2000793 | 2 | 0.033 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.033 | |
| cellular magnesium ion homeostasis | GO:0010961 | 3 | 0.033 | |
| axonogenesis | GO:0007409 | 274 | 0.032 | |
| regulation of coagulation | GO:0050818 | 31 | 0.032 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.032 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.032 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.032 | |
| stem cell differentiation | GO:0048863 | 268 | 0.031 | |
| skin development | GO:0043588 | 220 | 0.031 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.031 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.031 | |
| positive regulation of semaphorin plexin signaling pathway | GO:2001262 | 1 | 0.031 | |
| regulation of oligodendrocyte differentiation | GO:0048713 | 23 | 0.030 | |
| anion transport | GO:0006820 | 177 | 0.030 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.030 | |
| muscle cell development | GO:0055001 | 133 | 0.030 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.030 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.030 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.030 | Mouse |
| positive regulation of cell migration | GO:0030335 | 109 | 0.030 | |
| platelet formation | GO:0030220 | 12 | 0.030 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.030 | |
| cell maturation | GO:0048469 | 127 | 0.029 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.029 | |
| innate immune response activating signal transduction | GO:0002758 | 50 | 0.029 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.029 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.029 | |
| visceral serous pericardium development | GO:0061032 | 2 | 0.029 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.029 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.028 | |
| regulation of neuroblast proliferation | GO:1902692 | 27 | 0.028 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.028 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.028 | |
| auditory receptor cell fate determination | GO:0042668 | 3 | 0.028 | |
| positive regulation of mechanoreceptor differentiation | GO:0045633 | 1 | 0.028 | |
| forebrain development | GO:0030900 | 302 | 0.027 | |
| positive regulation of stem cell differentiation | GO:2000738 | 23 | 0.027 | |
| sclerotome development | GO:0061056 | 4 | 0.027 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.027 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.027 | |
| locomotory behavior | GO:0007626 | 195 | 0.027 | |
| response to peptide hormone | GO:0043434 | 127 | 0.027 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.027 | |
| activation of innate immune response | GO:0002218 | 56 | 0.027 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.026 | |
| rhythmic process | GO:0048511 | 174 | 0.026 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.026 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.026 | |
| chromatin organization | GO:0006325 | 206 | 0.026 | |
| organelle assembly | GO:0070925 | 177 | 0.026 | |
| tissue homeostasis | GO:0001894 | 115 | 0.026 | |
| placenta development | GO:0001890 | 140 | 0.026 | |
| positive regulation of cd8 positive alpha beta t cell extravasation | GO:2000451 | 2 | 0.026 | |
| axon guidance | GO:0007411 | 141 | 0.026 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.025 | |
| regulation of interleukin 10 production | GO:0032653 | 21 | 0.025 | |
| response to radiation | GO:0009314 | 165 | 0.025 | |
| regulation of histone modification | GO:0031056 | 56 | 0.025 | |
| regulation of keratinocyte proliferation | GO:0010837 | 15 | 0.025 | |
| retina morphogenesis in camera type eye | GO:0060042 | 45 | 0.025 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.025 | |
| granzyme mediated apoptotic signaling pathway | GO:0008626 | 1 | 0.025 | |
| norepinephrine secretion | GO:0048243 | 2 | 0.025 | |
| male gamete generation | GO:0048232 | 285 | 0.025 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.025 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.025 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.025 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.025 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.025 | |
| striated muscle cell development | GO:0055002 | 125 | 0.024 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.024 | |
| cation transport | GO:0006812 | 399 | 0.024 | |
| epithelial structure maintenance | GO:0010669 | 9 | 0.024 | |
| bone morphogenesis | GO:0060349 | 78 | 0.024 | |
| hindbrain development | GO:0030902 | 128 | 0.024 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.024 | |
| limb development | GO:0060173 | 166 | 0.024 | |
| response to growth factor | GO:0070848 | 198 | 0.023 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.023 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.023 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.023 | |
| palate development | GO:0060021 | 76 | 0.023 | |
| feeding behavior | GO:0007631 | 62 | 0.023 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.023 | |
| t cell receptor signaling pathway | GO:0050852 | 46 | 0.023 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.023 | |
| protein acylation | GO:0043543 | 64 | 0.023 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.022 | |
| limb morphogenesis | GO:0035108 | 149 | 0.022 | |
| cellular response to follicle stimulating hormone stimulus | GO:0071372 | 1 | 0.022 | |
| negative regulation of type b pancreatic cell apoptotic process | GO:2000675 | 3 | 0.022 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.022 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.022 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.022 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.022 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.022 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.022 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 73 | 0.022 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 58 | 0.022 | |
| maintenance of location | GO:0051235 | 89 | 0.022 | |
| histone modification | GO:0016570 | 159 | 0.022 | |
| t cell activation | GO:0042110 | 289 | 0.022 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.022 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.022 | |
| trophoblast giant cell differentiation | GO:0060707 | 15 | 0.021 | |
| skeletal system development | GO:0001501 | 356 | 0.021 | |
| cellular response to lipid | GO:0071396 | 145 | 0.021 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.021 | |
| telencephalon development | GO:0021537 | 186 | 0.021 | |
| ossification | GO:0001503 | 216 | 0.021 | |
| neuroblast proliferation | GO:0007405 | 49 | 0.021 | |
| angiogenesis | GO:0001525 | 201 | 0.021 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.021 | |
| oligodendrocyte differentiation | GO:0048709 | 53 | 0.021 | |
| regulation of monocyte extravasation | GO:2000437 | 2 | 0.020 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.020 | |
| subpallium neuron fate commitment | GO:0060163 | 2 | 0.020 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.020 | |
| regulation of blood coagulation | GO:0030193 | 28 | 0.020 | |
| face morphogenesis | GO:0060325 | 29 | 0.020 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.020 | |
| compound eye development | GO:0048749 | 1 | 0.020 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.020 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.020 | |
| digestive tract development | GO:0048565 | 190 | 0.020 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.020 | |
| cell division | GO:0051301 | 120 | 0.020 | |
| spermatogenesis | GO:0007283 | 284 | 0.020 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.020 | |
| positive regulation of myeloid cell differentiation | GO:0045639 | 43 | 0.020 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.020 | |
| muscle tissue development | GO:0060537 | 308 | 0.020 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.020 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.020 | |
| nuclear transport | GO:0051169 | 139 | 0.020 | |
| myotube differentiation | GO:0014902 | 105 | 0.020 | |
| cell cell adhesion | GO:0098609 | 41 | 0.020 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.019 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.019 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.019 | |
| camera type eye photoreceptor cell differentiation | GO:0060219 | 15 | 0.019 | |
| regulation of cell projection assembly | GO:0060491 | 38 | 0.019 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.019 | |
| regulation of secretion | GO:0051046 | 274 | 0.019 | |
| septum primum development | GO:0003284 | 4 | 0.019 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.019 | |
| pattern recognition receptor signaling pathway | GO:0002221 | 47 | 0.019 | |
| positive regulation of monocyte extravasation | GO:2000439 | 1 | 0.019 | |
| nuclear import | GO:0051170 | 95 | 0.019 | |
| regulation of defense response | GO:0031347 | 233 | 0.019 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.019 | |
| glial cell differentiation | GO:0010001 | 131 | 0.019 | |
| cellular response to calcium ion | GO:0071277 | 14 | 0.019 | |
| regulation of epithelial to mesenchymal transition | GO:0010717 | 22 | 0.019 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.018 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.018 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.018 | Mouse |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.018 | |
| negative regulation of chromatin modification | GO:1903309 | 19 | 0.018 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.018 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.018 | |
| striated muscle adaptation | GO:0014888 | 26 | 0.018 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.018 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.018 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.018 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.018 | |
| mapk cascade | GO:0000165 | 281 | 0.018 | |
| cellular glucose homeostasis | GO:0001678 | 52 | 0.018 | |
| glucose transport | GO:0015758 | 56 | 0.018 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.018 | |
| hydrogen transport | GO:0006818 | 35 | 0.018 | |
| hormone secretion | GO:0046879 | 128 | 0.018 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.018 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.018 | |
| ovulation cycle | GO:0042698 | 59 | 0.017 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.017 | |
| glial cell fate commitment | GO:0021781 | 14 | 0.017 | |
| regulation of cell activation | GO:0050865 | 289 | 0.017 | |
| negative regulation of biomineral tissue development | GO:0070168 | 11 | 0.017 | |
| nuclear division | GO:0000280 | 158 | 0.017 | |
| regulation of circadian rhythm | GO:0042752 | 58 | 0.017 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.017 | |
| tendon formation | GO:0035992 | 4 | 0.017 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.017 | |
| regulation of ion transport | GO:0043269 | 215 | 0.017 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.017 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.017 | |
| stem cell proliferation | GO:0072089 | 117 | 0.017 | |
| macromolecule methylation | GO:0043414 | 120 | 0.017 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.017 | |
| negative regulation of gliogenesis | GO:0014014 | 23 | 0.017 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.017 | |
| body morphogenesis | GO:0010171 | 45 | 0.017 | |
| tumor necrosis factor production | GO:0032640 | 50 | 0.017 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.017 | |
| head morphogenesis | GO:0060323 | 34 | 0.017 | |
| interleukin 10 production | GO:0032613 | 23 | 0.017 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.017 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.017 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.016 | |
| eosinophil activation | GO:0043307 | 1 | 0.016 | |
| endodermal cell fate determination | GO:0007493 | 2 | 0.016 | |
| primitive hemopoiesis | GO:0060215 | 7 | 0.016 | |
| humoral immune response | GO:0006959 | 57 | 0.016 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.016 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.016 | |
| membrane organization | GO:0061024 | 245 | 0.016 | |
| face development | GO:0060324 | 38 | 0.016 | |
| regulation of action potential | GO:0098900 | 4 | 0.016 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.016 | |
| defense response to virus | GO:0051607 | 68 | 0.016 | |
| endomembrane system organization | GO:0010256 | 147 | 0.016 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.016 | |
| tendon cell differentiation | GO:0035990 | 4 | 0.016 | |
| organelle localization | GO:0051640 | 179 | 0.016 | |
| regulation of protein transport | GO:0051223 | 163 | 0.016 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.016 | |
| positive regulation of neuroblast proliferation | GO:0002052 | 19 | 0.016 | |
| dendrite development | GO:0016358 | 115 | 0.016 | |
| regulation of gliogenesis | GO:0014013 | 50 | 0.016 | |
| cell recognition | GO:0008037 | 83 | 0.016 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.016 | |
| sperm motility | GO:0030317 | 47 | 0.016 | |
| regulation of ossification | GO:0030278 | 112 | 0.015 | |
| regulation of stem cell differentiation | GO:2000736 | 50 | 0.015 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.015 | |
| ear morphogenesis | GO:0042471 | 118 | 0.015 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.015 | |
| cellular response to gonadotropin stimulus | GO:0071371 | 4 | 0.015 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.015 | |
| conditioned taste aversion | GO:0001661 | 4 | 0.015 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.015 | |
| proton transport | GO:0015992 | 35 | 0.015 | |
| negative regulation of chromosome organization | GO:2001251 | 30 | 0.015 | |
| ear development | GO:0043583 | 200 | 0.015 | |
| t cell selection | GO:0045058 | 34 | 0.015 | |
| response to nutrient levels | GO:0031667 | 109 | 0.015 | |
| multi organism behavior | GO:0051705 | 62 | 0.015 | |
| response to bmp | GO:0071772 | 14 | 0.015 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.015 | |
| tumor necrosis factor superfamily cytokine production | GO:0071706 | 51 | 0.015 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.015 | |
| oligopeptide transmembrane transport | GO:0035672 | 4 | 0.015 | |
| negative regulation of complement activation | GO:0045916 | 3 | 0.015 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.015 | |
| antigen receptor mediated signaling pathway | GO:0050851 | 64 | 0.015 | |
| regulation of angiotensin levels in blood | GO:0002002 | 4 | 0.015 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.015 | |
| negative regulation of cell fate specification | GO:0009996 | 4 | 0.015 | |
| cognition | GO:0050890 | 149 | 0.014 | |
| regulation of norepinephrine secretion | GO:0014061 | 2 | 0.014 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.014 | |
| eosinophil mediated immunity | GO:0002447 | 1 | 0.014 | |
| positive regulation of epidermal cell differentiation | GO:0045606 | 6 | 0.014 | |
| negative regulation of vasculature development | GO:1901343 | 26 | 0.014 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.014 | |
| hematopoietic stem cell migration | GO:0035701 | 1 | 0.014 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.014 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.014 | |
| positive regulation of t cell proliferation | GO:0042102 | 52 | 0.014 | |
| positive regulation of catecholamine secretion | GO:0033605 | 2 | 0.014 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.014 | |
| cd8 positive alpha beta t cell extravasation | GO:0035697 | 3 | 0.014 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.014 | |
| generation of ovulation cycle rhythm | GO:0060112 | 1 | 0.014 | |
| regulation of antimicrobial peptide biosynthetic process | GO:0002805 | 1 | 0.014 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.014 | |
| positive regulation of exit from mitosis | GO:0031536 | 1 | 0.014 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.014 | |
| peptide transport | GO:0015833 | 133 | 0.014 | |
| negative regulation of homeostatic process | GO:0032845 | 71 | 0.014 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.014 | |
| intracellular protein transport | GO:0006886 | 204 | 0.014 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.014 | |
| positive regulation of mitochondrial calcium ion concentration | GO:0051561 | 3 | 0.014 | |
| regulation of peptidyl lysine acetylation | GO:2000756 | 22 | 0.014 | |
| bone mineralization | GO:0030282 | 54 | 0.014 | |
| leukocyte migration | GO:0050900 | 124 | 0.014 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.014 | |
| regulation of tumor necrosis factor superfamily cytokine production | GO:1903555 | 50 | 0.014 | |
| negative regulation of interleukin 5 production | GO:0032714 | 4 | 0.013 | |
| metencephalon development | GO:0022037 | 89 | 0.013 | |
| gastrulation | GO:0007369 | 116 | 0.013 | |
| muscle contraction | GO:0006936 | 101 | 0.013 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.013 | |
| regulation of interleukin 4 biosynthetic process | GO:0045402 | 3 | 0.013 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.013 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.013 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.013 | |
| regulation of alpha beta t cell activation | GO:0046634 | 53 | 0.013 | |
| cellular response to hexose stimulus | GO:0071331 | 47 | 0.013 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.013 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.013 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.013 | |
| behavioral defense response | GO:0002209 | 28 | 0.013 | |
| multicellular organismal reproductive behavior | GO:0033057 | 23 | 0.013 | |
| leukocyte mediated cytotoxicity | GO:0001909 | 62 | 0.013 | |
| cell junction organization | GO:0034330 | 77 | 0.013 | |
| negative regulation of mesodermal cell fate specification | GO:0042662 | 3 | 0.013 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.013 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.013 | |
| regulation of hematopoietic stem cell migration | GO:2000471 | 1 | 0.013 | |
| phenol containing compound biosynthetic process | GO:0046189 | 21 | 0.013 | |
| negative regulation of ion transport | GO:0043271 | 28 | 0.013 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.013 | |
| negative regulation of blood coagulation | GO:0030195 | 11 | 0.013 | |
| regulation of translational initiation in response to stress | GO:0043558 | 5 | 0.013 | Mouse |
| deltoid tuberosity development | GO:0035993 | 3 | 0.013 | |
| positive regulation of immunological synapse formation | GO:2000522 | 1 | 0.013 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.013 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.013 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.013 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.013 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.013 | |
| transepithelial chloride transport | GO:0030321 | 4 | 0.013 | |
| mitochondrion organization | GO:0007005 | 134 | 0.013 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.013 | |
| anion transmembrane transport | GO:0098656 | 71 | 0.013 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.013 | |
| eosinophil activation involved in immune response | GO:0002278 | 1 | 0.013 | |
| primary neural tube formation | GO:0014020 | 95 | 0.013 | |
| gonad development | GO:0008406 | 141 | 0.013 | |
| negative regulation of histone modification | GO:0031057 | 18 | 0.013 | |
| internal peptidyl lysine acetylation | GO:0018393 | 42 | 0.013 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.013 | |
| positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation | GO:2000526 | 1 | 0.013 | |
